Composition and method for the enhancement of the efficacy of drugs
View Patent ↗The present invention relates to the enhancement of the efficacy of drugs, and more particularly, with overcoming the resistance of cells or organisms to drugs. In particular, the present invention provides a method for enhancing the effectiveness of a cytotoxic or anti-neoplastic agent, comprising the step of co-administering said agent with hyaluronan, wherein co-administration with hyaluronan enhances the agent's cancer cell-killing potential.
1. A pharmaceutical composition comprising hyaluronan and an anticancer chemotherapeutic agent, wherein said composition is administered intravenously, the concentration of said hyaluronan is ≧1 gram per liter, and wherein the hyaluronan has a molecular weight of about 890 KDa.
2. The pharmaceutical composition of claim 1 , wherein the hyaluronan elutes within ±10 ml of the fraction with a molecular weight of 890 KDa as analyzed on a Sephacryl S-1000 1.6 cm×70 cm size exclusion gel column with a fraction size of 2 ml and flow rate of 18 ml/h.
3. The pharmaceutical composition of claim 1 , wherein the hyaluronan has a polydispersity of 1.78.
4. The pharmaceutical composition of claim 1 , wherein the chemotherapeutic agent is selected from the group consisting of methotrexate, paclitaxel, 5-fluorouracil and cyclophosphamide or combinations thereof.
5. The pharmaceutical composition of claim 1 , wherein the chemotherapeutic agent is cyclophosphamide.
6. The pharmaceutical composition of claim 1 , wherein the chemotherapeutic agent is paclitaxel.